Cancer promotion can be regulated by several pathways associated with inflammation, such as those involving NF-κB, STAT3, mTOR, and MAPKs, which are triggered by pro-inflammatory cytokines like IL-6, TNF-α, and IL-1β [29]. This evidence concerns the gene STAT3 and cancer.